An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Janssen COVID-19 Vaccine

Chemical NameJanssen COVID-19 Vaccine
Dosage FormInjection (intramuscular; 0.5mL)
Drug ClassVaccines
SystemRespiratory
CompanyJanssen Pharmaceuticals
Approval Year2022

Indication

  • Authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older
Last updated on 4/23/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Janssen COVID-19 Vaccine Prescribing Information.2022Janssen Biotech, Inc., Horsham, PA
Document TitleYearSource
Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: a systematic review. 2022Journal of Medical Virology
Evaluation of the safety profile of COVID-19 vaccines: a rapid review.2021BMC Medicine